| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | 0.29 | 0.09 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.09 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.09 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.061 | 0.09 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | -0.065 | 0.09 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.09 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.09 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.09 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.065 | 0.09 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.086 | 0.09 |